Navigating Barriers to Molecular Testing and Role of Liquid Biopsy in NSCLC

By Martin Dietrich, MD, PhD
Meghan J. Mooradian, MD

Expert oncologists discuss barriers to molecular testing and the use of liquid biopsy in non–small cell lung cancer.

Related Videos
View All
Related Content

FDA Approves Adjuvant Pembrolizumab in NSCLC

January 26th 2023

Dy Discusses CEACAM5-Directed and Other Second-Line Treatment Strategies in NSCLC

January 19th 2023

Perioperative Toripalimab Plus Chemotherapy Meets EFS End Point in NSCLC

January 18th 2023

FDA Approval Insights: Tremelimumab Plus Durvalumab and Chemotherapy in NSCLC

December 15th 2022

Spira Highlights Key Advancements Across the NSCLC Treatment Paradigm in 2022

January 11th 2023

Mobocertinib Garners Approval in China for EGFR Exon 20 Insertion+ NSCLC

January 11th 2023

FDA Approves Adjuvant Pembrolizumab in NSCLC

January 26th 2023

Dy Discusses CEACAM5-Directed and Other Second-Line Treatment Strategies in NSCLC

January 19th 2023

Perioperative Toripalimab Plus Chemotherapy Meets EFS End Point in NSCLC

January 18th 2023

FDA Approval Insights: Tremelimumab Plus Durvalumab and Chemotherapy in NSCLC

December 15th 2022

Spira Highlights Key Advancements Across the NSCLC Treatment Paradigm in 2022

January 11th 2023

Mobocertinib Garners Approval in China for EGFR Exon 20 Insertion+ NSCLC

January 11th 2023

FDA Approves Adjuvant Pembrolizumab in NSCLC

January 26th 2023

Dy Discusses CEACAM5-Directed and Other Second-Line Treatment Strategies in NSCLC

January 19th 2023

Perioperative Toripalimab Plus Chemotherapy Meets EFS End Point in NSCLC

January 18th 2023

FDA Approval Insights: Tremelimumab Plus Durvalumab and Chemotherapy in NSCLC

December 15th 2022

Spira Highlights Key Advancements Across the NSCLC Treatment Paradigm in 2022

January 11th 2023

Mobocertinib Garners Approval in China for EGFR Exon 20 Insertion+ NSCLC

January 11th 2023
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact